On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against ...

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...

MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.

The HPV vaccine can prevent cancers, including cervical cancer. It's recommended for girls between the ages nine and 45. Only ...

Varanasi: An awareness programme was organised by Sathiya Kendra of the Institute of Medical Sciences (IMS), Banaras Hindu ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid an escalating trade war between ...

More women than ever are being screened for cervical cancer, suggesting a policy change made just a few years ago is having a ...

The company’s stock fell as much as 2.8% after markets opened in New York Thursday. For the first quarter, Merck’s results ...

Proquad is rarely a newsmaker from Merck’s earnings, but this time around, the U.S. has had a series of measles outbreaks.

Merck stock could take another hit Thursday after the company reported another quarter of light sales for its HPV vaccine, ...

A steep fall in demand from China drove a 41% decline in MSD Q1 2025 sales of its human papillomavirus (HPV) vaccines Gardasil and Gardasil 9, marking a continued setback for the company’s ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid an escalating trade war between the US and China, where demand for its blockbuster Gardasil vaccine is ...